GB2303303B - Medical treatment - Google Patents
Medical treatmentInfo
- Publication number
- GB2303303B GB2303303B GB9614578A GB9614578A GB2303303B GB 2303303 B GB2303303 B GB 2303303B GB 9614578 A GB9614578 A GB 9614578A GB 9614578 A GB9614578 A GB 9614578A GB 2303303 B GB2303303 B GB 2303303B
- Authority
- GB
- United Kingdom
- Prior art keywords
- medical treatment
- medical
- treatment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9514384.8A GB9514384D0 (en) | 1995-07-13 | 1995-07-13 | Medical treatment |
Publications (3)
Publication Number | Publication Date |
---|---|
GB9614578D0 GB9614578D0 (en) | 1996-09-04 |
GB2303303A GB2303303A (en) | 1997-02-19 |
GB2303303B true GB2303303B (en) | 1999-09-15 |
Family
ID=10777630
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GBGB9514384.8A Pending GB9514384D0 (en) | 1995-07-13 | 1995-07-13 | Medical treatment |
GB9614578A Expired - Fee Related GB2303303B (en) | 1995-07-13 | 1996-07-11 | Medical treatment |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GBGB9514384.8A Pending GB9514384D0 (en) | 1995-07-13 | 1995-07-13 | Medical treatment |
Country Status (1)
Country | Link |
---|---|
GB (2) | GB9514384D0 (en) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU8130298A (en) * | 1997-07-15 | 1999-02-10 | Sankyo Company Limited | Piperazine derivatives |
UA66370C2 (en) * | 1997-12-16 | 2004-05-17 | Lilly Co Eli | Arylpiperazines having activity to setotonin 1 receptors |
EP1161241B1 (en) | 1999-03-12 | 2005-12-07 | Aesica Pharmaceuticals Ltd. | Stable pharmaceutical application form for paroxetin anhydrate |
UA77650C2 (en) * | 1999-12-06 | 2007-01-15 | Lundbeck & Co As H | Use of serotonin reuptake inhibitor in combination with deramcyclane |
EP1266659A1 (en) * | 2001-06-11 | 2002-12-18 | Pantarhei Bioscience B.V. | Pyridoxal in combination with serotonin re-uptake inhibitor for the treatment of hot flushes |
ITMI20021327A1 (en) * | 2002-06-14 | 2003-12-15 | Recordati Chem Pharm | NEW OSSIALCHILPIPERAZINE |
CN102659774A (en) | 2005-08-15 | 2012-09-12 | 弗·哈夫曼-拉罗切有限公司 | Piperidine and piperazine derivatives as P2X3 antagonists |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4698342A (en) * | 1985-07-16 | 1987-10-06 | Serotonin Industries Of Charleston | Method and compositions for controlling pain, depression and sedation |
WO1996003400A1 (en) * | 1994-07-26 | 1996-02-08 | Pfizer Inc. | 4-indole derivatives as serotonin agonists and antagonists |
EP0722941A2 (en) * | 1995-01-17 | 1996-07-24 | Eli Lilly And Company | Compounds having effects on serotonin-related systems |
-
1995
- 1995-07-13 GB GBGB9514384.8A patent/GB9514384D0/en active Pending
-
1996
- 1996-07-11 GB GB9614578A patent/GB2303303B/en not_active Expired - Fee Related
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4698342A (en) * | 1985-07-16 | 1987-10-06 | Serotonin Industries Of Charleston | Method and compositions for controlling pain, depression and sedation |
WO1996003400A1 (en) * | 1994-07-26 | 1996-02-08 | Pfizer Inc. | 4-indole derivatives as serotonin agonists and antagonists |
EP0722941A2 (en) * | 1995-01-17 | 1996-07-24 | Eli Lilly And Company | Compounds having effects on serotonin-related systems |
Non-Patent Citations (1)
Title |
---|
TIPS, Vol. 14, July 1993, p 262 * |
Also Published As
Publication number | Publication date |
---|---|
GB9514384D0 (en) | 1995-09-13 |
GB9614578D0 (en) | 1996-09-04 |
GB2303303A (en) | 1997-02-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB2298440B (en) | Well treatment | |
IL128850A0 (en) | Medical treatment | |
AU6913796A (en) | Patient treatment apparatus | |
HUP9901089A3 (en) | Medical splint | |
GB9519033D0 (en) | Treatment | |
GB2303303B (en) | Medical treatment | |
GB9521725D0 (en) | Medical treatment | |
HUP9901448A3 (en) | Novel medical use | |
GB9217124D0 (en) | Medical treatment | |
GB9408084D0 (en) | Medical treatment | |
GB9526264D0 (en) | Medical treatment | |
GB2307858B (en) | Medical treatment | |
GB9508438D0 (en) | Medical treatment | |
GB9425164D0 (en) | Medical treatment | |
GB9424728D0 (en) | Medical treatment | |
GB9403306D0 (en) | Medical treatment | |
GB9425773D0 (en) | Medical treatment | |
GB9421398D0 (en) | Medical treatment | |
GB9621327D0 (en) | Medical treatment | |
GB9602728D0 (en) | Medical treatment | |
GB9618375D0 (en) | Medical treatment | |
GB9612330D0 (en) | Medical treatment | |
GB9626859D0 (en) | Medical treatment | |
GB9626265D0 (en) | Medical treatment | |
GB9321793D0 (en) | Medical treatment |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PCNP | Patent ceased through non-payment of renewal fee |
Effective date: 20080711 |